Previous Close | 7.6 |
1-Year Change | 1.88% |
6-Months Change | 35.96% |
3-Months Change | 28.38% |
Moving Avg (50d) | 7.3546 |
Moving Avg (200d) | 6.5007 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 305.6M |
Beta (3-Years) | 0.98 |
Revenue Growth (ttm) | 4.71% |
Net Profit Margin (ttm) | 1.92% |
Return On Assets (ttm) | 1.3% |
EPS (ttm) | 0.16 |
PE Ratio (ttm) | 47.5 |
Dividend Yield | % |
Asset Description: | AngioDynamics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
7.448 | 7.22 | 7.068 | 6.84 | 6.46 | 6.08 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |